Page last updated: 2024-08-26
lopinavir and je 2147
lopinavir has been researched along with je 2147 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hayashi, H; Mimoto, T; Nojima, S; Shintani, M; Takaku, H; Terashima, K | 1 |
| Abdel-Rahman, HM; Adachi, M; Hayashi, Y; Hidaka, K; Katsuki, N; Kempf, DJ; Kimura, T; Kiso, Y; Kohlbrenner, WE; Kuroki, R; Matsumoto, H; McDaniel, KF; Molla, A; Nguyen, JT; Tamada, T; Tanaka, Y; Wang, J | 1 |
| Adachi, M; Hayashi, Y; Hidaka, K; Kameoka, M; Kempf, DJ; Kimura, T; Kiso, Y; Kuroki, R; McDaniel, KF; Nguyen, JT; Sankaranarayanan, R; Wang, J | 1 |
Other Studies
3 other study(ies) available for lopinavir and je 2147
| Article | Year |
|---|---|
Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
Topics: Animals; Dogs; Drug Design; Hepatocytes; HIV Protease Inhibitors; HIV-1; Humans; Molecular Structure; Mutation; Phenylbutyrates; Sensitivity and Specificity; Structure-Activity Relationship | 2008 |
Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.
Topics: Cell Line; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Models, Molecular; Molecular Conformation; Phenylbutyrates; Structure-Activity Relationship; Substrate Specificity | 2009 |
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 Tetrahydrofuranylglycine.
Topics: Crystallography, X-Ray; Darunavir; Drug Resistance, Viral; Glycine; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Peptidomimetics; Phenylbutyrates; Serum; Structure-Activity Relationship | 2018 |